Phase III randomized study of fotemustine and dacarbazine versus ...

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients ...

Herein, the authors report the results of a Phase II trial with this regimen. METHODS. From June 1996 to February 1999, 64 patients with ...

Biochemotherapy in the treatment of metastatic melanoma in ...

... randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. ... Phase III Randomized Clinical Trial. J Clin ...

Overall survival and histology-specific subgroup analyses from a

BACKGROUND: We performed a randomized phase 3 study of trabectedin versus dacarbazine in previously-treated patients with liposarcoma ...

Fotemustine - Drug Targets, Indications, Patents - Patsnap Synapse

A randomized, Phase III study of Fotemustine versus the Combination of Fotemustine and Ipilimumab in Patients with Metastatic Melanoma with brain metastasis.

Evolving Role of Chemotherapy-Based Treatment of Metastatic ...

... randomized trial of the Dartmouth regimen versus dacarbazine in ... versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

Phase ii trial with alkylating agents dacarbazine and fotemustine in ...

Article: Phase ii trial with alkylating agents dacarbazine and fotemustine in the treatment of advanced malignant melanoma amm from antagonism to s.

Phase III randomized study of fotemustine and dacarbazine ... - CNR

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-alpha in advanced malignant melanoma (Articolo in ...

(PDF) Combination chemotherapy of dacarbazine and fotemustine ...

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma · Bruno Massidda.

Fotemustine Compared With Dacarbazine in Patients ... - Altmetric

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study · Journal of Clinical Oncology, March 2004 · 10.1200/jco ...

Melanoma metastatic fotemustine three weekly maintenance ... - eviQ

A phase III study compared fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, duration ...

Voltar - Portal .periodicos. CAPES

Publicação - Artigo Revisado por pares. Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus ...